Table 3.
Study | 25OHD Measurement Method | n | EAF (A Allelea) | Betab | Standard Error | p Value | Information Score |
---|---|---|---|---|---|---|---|
ALSPAC imputed | MS | 3,675 | 0.028 | −0.59 | 0.07 | 3.43 × 10−18 | 0.99 |
ALSPAC WGS | MS | 1,606 | 0.028 | −0.65 | 0.11 | 8.23 × 10−10 | NA |
BPROOF | MS | 2,512 | 0.027 | −0.4 | 0.09 | 4.99 × 10−6 | 0.97 |
BMDCS | MS | 863 | 0.019 | −0.11 | 0.06 | 0.058 | 0.98 |
CHS | MS | 1,581 | 0.022 | −0.55 | 0.11 | 5.15 × 10−7 | 0.88 |
FHS | CLIA | 5,402 | 0.021 | −0.45 | 0.07 | 2.32 × 10−10 | 0.97 |
GenerationR | MS | 1,442 | 0.033 | −0.66 | 0.1 | 1.78 × 10−6 | 1 |
GOOD | CLIA | 921 | 0.028 | −0.14 | 0.14 | 0.31 | 0.96 |
MrOS | MS | 3,265 | 0.018 | −0.76 | 0.09 | 5.63 × 10−16 | 0.96 |
MrOS Malmo | CLIA | 893 | 0.033 | −0.33 | 0.14 | 0.016 | 0.94 |
MrOS GBG | CLIA | 945 | 0.026 | −0.61 | 0.14 | 7.87 × 10−6 | 1 |
NEO | MS | 5,727 | 0.025 | −0.54 | 0.06 | 2.73 × 10−19 | 1 |
PIVUS | CLIA | 943 | 0.028 | −0.66 | 0.14 | 2.56 × 10−6 | 0.99 |
RSI | ECLIA | 3,320 | 0.025 | −0.19 | 0.08 | 0.019 | 0.98 |
RSII | ECLIA | 2,022 | 0.033 | −0.37 | 0.09 | 2.38 × 10−5 | 0.99 |
RSIII | ECLIA | 2,913 | 0.027 | −0.51 | 0.08 | 4.61 × 10−10 | 0.98 |
TUK imputed | CLIA | 1,919 | 0.021 | −0.1 | 0.11 | 0.35 | 0.98 |
TUK WGS | CLIA | 1,013 | 0.025 | −0.39 | 0.14 | 0.006 | NA |
ULSAM | MS | 1,095 | 0.025 | −0.33 | 0.14 | 0.02 | 1 |
Abbreviations are as follows: CLIA, chemiluminescence immunoassay; EAF, effect allele frequency; ECLIA, electrochemiluminescence immunoassay; MS, mass spectrometry; NA, not applicable; 25OHD, 25-hydroxyvitamin D.
Effect allele is the 25OHD decreasing allele.
Beta values represent changes in standard deviations of the standardized log-transformed 25OHD levels.